Stay updated on Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site’s footer release/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor system/content release without changing the study information shown on the page.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.5.2; previous v3.5.0 label removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:30.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added related topic 'Carcinoma of male breast' and a link to Genetic and Rare Diseases Information Center resources.
    Difference
    0.2%
    Check dated 2026-04-02T15:22:57.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:25:06.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.4.3 released, updating from v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:20.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag appeared, and the prior government funding/operating status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:11:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Paclitaxel in HER2- Breast Cancer Clinical Trial page.